Systemic chemotherapy of murine bladder cancer.
D000818:Animals; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use* / Q000633:toxicity; D002295:Carcinoma, Transitional Cell / Q000139:chemically induced / Q000188:drug therapy* / Q000473:pathology; D002460:Cell Line; D002945:Cisplatin / Q000008:administration & dosage / Q000633:toxicity; D004195:Disease Models, Animal; D004305:Dose-Response Relationship, Drug; D005047:Etoposide / Q000008:administration & dosage / Q000633:toxicity; D005200:FANFT; D005260:Female; D008727:Methotrexate / Q000008:administration & dosage / Q000633:toxicity; D051379:Mice; D008809:Mice, Inbred C3H; D009368:Neoplasm Transplantation; D001749:Urinary Bladder Neoplasms / Q000139:chemically induced / Q000188:drug therapy* / Q000473:pathology
D005047:Etoposide; D005200:FANFT; D002945:Cisplatin; D008727:Methotrexate